FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048491978> ?p ?o ?g. }

• W3048491978 endingPage "e0237447" @default.
• W3048491978 startingPage "e0237447" @default.
• W3048491978 abstract "Background Extracorporeal shock wave therapy (ESWT) has been used as a safe alternative treatment for refractory musculoskeletal diseases, such as plantar fasciitis, Achilles tendinopathy and gluteal tendinopathy, and various forms of fibromatosis including palmar or penile fibromatosis. However, there is limited published data for clinical and sonographic features of plantar fibromatosis after ESWT. The purpose of this study was to evaluate the long-term clinical outcome of ESWT in ultrasonography-confirmed plantar fibromatosis and ultrasonographic changes of plantar fibroma after ESWT. Methods Medical charts of 26 patients (30 feet) with plantar fibromatosis confirmed by ultrasonography were reviewed. Finally, a total of 10 feet who underwent ESWT for “Poor” or “Fair” grade of Roles-Maudsley Score (RMS) and symptoms persisted for >6 months were included in this study. Short-term follow-up was conducted one week after ESWT and long-term follow-up time averaged 34.0 months. The Numerical Rating Scale (NRS) and RMS were collected for the evaluation of clinical features. Follow-up ultrasonography was conducted at long-term follow-up and changes of plantar fibroma was assessed. A greater than 50% reduction in the NRS and achievement of a “good” or “excellent” grade in the RMS were regarded as treatment success. Additionally, medical charts of 144 patients (168 feet) with plantar fasciitis confirmed by ultrasonography were reviewed and subsequently, 42 feet who underwent ESWT with the same protocol were included for the comparison of clinical features. Results In plantar fibromatosis, baseline NRS (6.2 ± 1.3) and RMS (3.5 ± 0.5) were significantly improved at short-term follow-up (NRS, 1.8 ± 1.0; RMS, 2.0 ± 0.8, P < .001, respectively) and long-term follow-up (NRS, 0.6 ± 1.1; RMS, 1.4 ± 0.8, P < .001, respectively). Treatment success was recorded in seven feet (70.0%) at short-term follow-up and 8 feet (80%) at long-term follow-up, which is comparable to that of the plantar fasciitis group (28 feet, 66.7%; 35 feet, 83.3%, respectively). In long-term follow-up ultrasonography, mean fibroma thickness was reduced from 4.4±1.0 to 2.6±0.8 mm (P = .003); however, length and width were not significantly changed. There were no serious adverse effects. Conclusion While these are preliminary findings, and must be confirmed in a randomized placebo control study, ESWT can have a beneficial long-term effect on pain relief and functional outcomes in painful plantar fibromatosis. However, ESWT is unlikely to affect the ultrasonographic morphology of plantar fibroma, with the exception of reducing the thickness. Level of evidence Level III, retrospective cohort study." @default.
• W3048491978 created "2020-08-18" @default.
• W3048491978 creator A5017922574 @default.
• W3048491978 creator A5025182744 @default.
• W3048491978 creator A5028469412 @default.
• W3048491978 creator A5039750545 @default.
• W3048491978 creator A5041740314 @default.
• W3048491978 creator A5067319173 @default.
• W3048491978 creator A5069804465 @default.
• W3048491978 date "2020-08-10" @default.
• W3048491978 modified "2023-10-03" @default.
• W3048491978 title "Follow-up of clinical and sonographic features after extracorporeal shock wave therapy in painful plantar fibromatosis" @default.
• W3048491978 cites W1505121999 @default.
• W3048491978 cites W1582571814 @default.
• W3048491978 cites W1593625634 @default.
• W3048491978 cites W176320596 @default.
• W3048491978 cites W1975341748 @default.
• W3048491978 cites W1984623484 @default.
• W3048491978 cites W1986677098 @default.
• W3048491978 cites W1986724267 @default.
• W3048491978 cites W1991846705 @default.
• W3048491978 cites W2006529832 @default.
• W3048491978 cites W2052045918 @default.
• W3048491978 cites W2056219032 @default.
• W3048491978 cites W2059308017 @default.
• W3048491978 cites W2060456166 @default.
• W3048491978 cites W2084898615 @default.
• W3048491978 cites W2095604026 @default.
• W3048491978 cites W2097038066 @default.
• W3048491978 cites W2131578683 @default.
• W3048491978 cites W2138597094 @default.
• W3048491978 cites W2146511523 @default.
• W3048491978 cites W2172191757 @default.
• W3048491978 cites W2328881494 @default.
• W3048491978 cites W2338015263 @default.
• W3048491978 cites W2560588207 @default.
• W3048491978 cites W2566657866 @default.
• W3048491978 cites W2592958256 @default.
• W3048491978 cites W2794670609 @default.
• W3048491978 cites W2796312795 @default.
• W3048491978 cites W2803359464 @default.
• W3048491978 cites W2883221393 @default.
• W3048491978 cites W2904340576 @default.
• W3048491978 cites W2965041268 @default.
• W3048491978 cites W2969466194 @default.
• W3048491978 cites W3002663385 @default.
• W3048491978 doi "https://doi.org/10.1371/journal.pone.0237447" @default.
• W3048491978 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7416956" @default.
• W3048491978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32776988" @default.
• W3048491978 hasPublicationYear "2020" @default.
• W3048491978 type Work @default.
• W3048491978 sameAs 3048491978 @default.
• W3048491978 citedByCount "3" @default.
• W3048491978 countsByYear W30484919782023 @default.
• W3048491978 crossrefType "journal-article" @default.
• W3048491978 hasAuthorship W3048491978A5017922574 @default.
• W3048491978 hasAuthorship W3048491978A5025182744 @default.
• W3048491978 hasAuthorship W3048491978A5028469412 @default.
• W3048491978 hasAuthorship W3048491978A5039750545 @default.
• W3048491978 hasAuthorship W3048491978A5041740314 @default.
• W3048491978 hasAuthorship W3048491978A5067319173 @default.
• W3048491978 hasAuthorship W3048491978A5069804465 @default.
• W3048491978 hasBestOaLocation W30484919781 @default.
• W3048491978 hasConcept C105702510 @default.
• W3048491978 hasConcept C126838900 @default.
• W3048491978 hasConcept C141071460 @default.
• W3048491978 hasConcept C142724271 @default.
• W3048491978 hasConcept C2775983998 @default.
• W3048491978 hasConcept C2777069013 @default.
• W3048491978 hasConcept C2777217379 @default.
• W3048491978 hasConcept C2777248721 @default.
• W3048491978 hasConcept C2778911562 @default.
• W3048491978 hasConcept C2780105995 @default.
• W3048491978 hasConcept C2780724051 @default.
• W3048491978 hasConcept C529618451 @default.
• W3048491978 hasConcept C71924100 @default.
• W3048491978 hasConceptScore W3048491978C105702510 @default.
• W3048491978 hasConceptScore W3048491978C126838900 @default.
• W3048491978 hasConceptScore W3048491978C141071460 @default.
• W3048491978 hasConceptScore W3048491978C142724271 @default.
• W3048491978 hasConceptScore W3048491978C2775983998 @default.
• W3048491978 hasConceptScore W3048491978C2777069013 @default.
• W3048491978 hasConceptScore W3048491978C2777217379 @default.
• W3048491978 hasConceptScore W3048491978C2777248721 @default.
• W3048491978 hasConceptScore W3048491978C2778911562 @default.
• W3048491978 hasConceptScore W3048491978C2780105995 @default.
• W3048491978 hasConceptScore W3048491978C2780724051 @default.
• W3048491978 hasConceptScore W3048491978C529618451 @default.
• W3048491978 hasConceptScore W3048491978C71924100 @default.
• W3048491978 hasIssue "8" @default.
• W3048491978 hasLocation W30484919781 @default.
• W3048491978 hasLocation W30484919782 @default.
• W3048491978 hasLocation W30484919783 @default.
• W3048491978 hasLocation W30484919784 @default.
• W3048491978 hasOpenAccess W3048491978 @default.
• W3048491978 hasPrimaryLocation W30484919781 @default.
• W3048491978 hasRelatedWork W2086375792 @default.
• W3048491978 hasRelatedWork W2120390469 @default.

• next